RiboScreen<sup>TM</sup> Technology Delivers Small-Molecule Ribodrugs to Convert Ribosomal Proteins into Molecular Valves for Tailored Protein Production Levels in Rare and Prevalent Disease <sup>†</sup>. [PDF]
Edobor G +21 more
europepmc +1 more source
Evaluating the efficacy and safety of macrolide therapy in primary ciliary dyskinesia: A systematic review. [PDF]
Ghasempour Alamdari M +7 more
europepmc +1 more source
Glc7/PP1 triggers Paf1 complex dissociation from RNA polymerase II to enable transcription termination. [PDF]
Namjilsuren S, Arndt KM.
europepmc +1 more source
Canonical transcription termination mechanisms explain a minority of operons in cyanobacteria. [PDF]
Cascino JA +6 more
europepmc +1 more source
Profiling heterologous 3' terminator-dependent expression variation in <i>Aspergillus oryzae</i>. [PDF]
Zhang C +8 more
europepmc +1 more source
A Translational Roadmap for Neurological Nonsense Mutation Disorders. [PDF]
Li J, Zhu Z, Xu S.
europepmc +1 more source
SETD2 methyltransferase activity promotes correct transcription initiation and termination. [PDF]
Kopczyńska M +7 more
europepmc +1 more source
Rescuing TP53 from nonsense: novel triazoles for translational readthrough via optimized drug design. [PDF]
Ricci D +7 more
europepmc +1 more source
Turning premature stop codons into therapeutic opportunities. [PDF]
Williamson J, Jacków-Malinowska J.
europepmc +1 more source
The role of RNA modifications in cancer translational control. [PDF]
Joy M, Cleynen A, Shirokikh NE.
europepmc +1 more source

